What is Opko Health Inc (OPK) stock price today?

Opko Health Inc (OPK) currently trades at $1.11 per share. The stock has a market capitalization of $838.15M and a P/E ratio of —x.

Is OPK stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Opko Health Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Opko Health Inc's revenue and earnings?

Opko Health Inc has trailing twelve-month (TTM) revenue of $606.88M with profit margins of -37.20%. Earnings per share (EPS) is $-0.27.

Is OPK stock overvalued or undervalued?

Based on our DCF model, Opko Health Inc's intrinsic value is $3.45, representing a margin of safety of 63.77%. The stock currently trades at a P/E of —x.

OPK

Opko Health Inc

NASDAQ: OPK · HEALTHCARE · DIAGNOSTICS & RESEARCH

$1.11

-8.26% today

Updated 2026-04-29

Market cap

$838.15M

P/E ratio

—

P/S ratio

1.38x

EPS (TTM)

$-0.27

Dividend yield

—

52W range

$1 – $2

Volume

2.5M

Market cap

$838.15M

P/E ratio

—

P/S ratio

1.38x

EPS (TTM)

$-0.27

Dividend yield

—

52W range

$1 – $2

Volume

2.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.0

Growth

5.0

Quality

C+

2.0

Profitability

5.7

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$3.38

+204.77%

12-Month target

—

Intrinsic (DCF)

$3.45

Margin of safety

+63.77%

3 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 63.77% below intrinsic value

Risks

- Thin margins at -37.20%

- Negative free cash flow $-28.59M

- Revenue declining -19.20% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.00B	$863.50M	$713.14M	$606.88M	$606.88M
Net income	$-328.40M	$-188.86M	$-53.22M	$-225.73M	$-31.30M
EPS	—	—	—	—	$-0.27
Free cash flow	$-119.77M	$-44.47M	$-208.50M	$-190.82M	$-28.59M
Profit margin	-32.70%	-21.87%	-7.46%	-37.20%	-37.20%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-20	PAGANELLI, JOHN A	Buy	10,000	$1.14
2026-03-18	UPPALURI, SUBBARAO V	Buy	50,000	—
2025-11-21	FROST, PHILLIP MD ET AL	Buy	192,870	$1.34

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OPK	$838.15M	31	2.0	2.0	5.7	5.0	+63.77%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Opko Health Inc trades at $1.11. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $606.88M. with profit margins at -37.20%. Our DCF model estimates intrinsic value at $3.45.

Frequently asked questions

What is Opko Health Inc's stock price?

Opko Health Inc (OPK) trades at $1.11.

Is Opko Health Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $3.45.

What is the price target of Opko Health Inc (OPK)?

The analyst target price is $3.38, representing +204.8% upside from the current price of $1.11.

What is the intrinsic value of Opko Health Inc (OPK)?

Based on our DCF model, intrinsic value is $3.45, a +63.8% margin of safety versus $1.11.

What is Opko Health Inc's revenue?

TTM revenue is $606.88M.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.38x

ROE-17.10%

Beta1.49

50D MA$1.18

200D MA$1.32

Shares out0.76B

Float0.34B

Short ratio—

Avg volume2.5M

Performance

1 week-1.63%

1 month+10.00%

3 months-5.47%

YTD-3.97%

1 year—

3 years—

5 years—

Compare

OPK vs LLY →OPK vs JNJ →OPK vs ABBV →Stock screener →